Sodium Carbonate → Erythromycin ethyl succinate

HRID 1508608

반응식

HRID 1508608 반응식
[CH3:1][CH2:2][C@H:3]1[O:18][C:16](=[O:17])[C@H:15]([CH3:19])[C@@H:14]([O:20][C@@H:21]2[O:26][C@@H:25]([CH3:27])[C@H:24]([OH:28])[C@@:23]([O:30][CH3:31])([CH3:29])[CH2:22]2)[C@H:13]([CH3:32])[C@@H:12]([O:33][C@@H:34]2[O:39][C@H:38]([CH3:40])[CH2:37][C@H:36]([N:41]([CH3:43])[CH3:42])[C@H:35]2[OH:44])[C@@:11]([OH:46])([CH3:45])[CH2:10][C@@H:9]([CH3:47])[C:7](=[O:8])[C@H:6]([CH3:48])[C@@H:5]([OH:49])[C@@:4]1([OH:51])[CH3:50].C(=O)(O)[O-].[Na+].C(=O)([O-])[O-].[Na+].[Na+].C(=O)([O-])[O-].[K+].[K+].[Cl-].[C:70]([O:77][CH2:78][CH3:79])(=[O:76])[CH2:71][CH2:72][C:73]([O-])=[O:74].[Br-].C(OCC)(=O)CCC([O-])=O>CCOCC.O>[CH3:1][CH2:2][C@H:3]1[O:18][C:16](=[O:17])[C@H:15]([CH3:19])[C@@H:14]([O:20][C@@H:21]2[O:26][C@@H:25]([CH3:27])[C@H:24]([OH:28])[C@@:23]([O:30][CH3:31])([CH3:29])[CH2:22]2)[C@H:13]([CH3:32])[C@@H:12]([O:33][C@@H:34]2[O:39][C@H:38]([CH3:40])[CH2:37][C@H:36]([N:41]([CH3:42])[CH3:43])[C@H:35]2[O:44][C:73]([CH2:72][CH2:71][C:70]([O:77][CH2:78][CH3:79])=[O:76])=[O:74])[C@@:11]([OH:46])([CH3:45])[CH2:10][C@@H:9]([CH3:47])[C:7](=[O:8])[C@H:6]([CH3:48])[C@@H:5]([OH:49])[C@@:4]1([OH:51])[CH3:50]

참가 물질

9

반응물 6

HCID 10340Sodium CarbonateHCID 11430Potassium CarbonateHCID 12560Erythromycin2회HCID 516892Sodium BicarbonateHCID 18404837Monoethyl succinate chlorideHCID 86718268Monoethyl succinate bromide

생성물 1

HCID 443953Erythromycin ethyl succinate

시약·촉매·용매 2

HCID 962Water용매HCID 3283Diethyl Ether용매

반응 조건

온도
25 °C

실험 절차

The process for preparing erythromycin ethylsuccinate hydrate comprises: method A. in a reaction vessel, one or more of a C1-C6 lower alcohol, a C2-C6 lower nitrile, a C3-C8 lower ketone or C2-C8 lower ether is used as a solvent, to the solvent is added erythromycin, stirred at a temperature of 0-50° C. to dissolve erythromycin; to the solution is added sodium bicarbonate or sodium carbonate or potassium carbonate, and water, stirred, and cooled to 20° C. or below; to the cooled mixture is added monoethyl succinate halide, including monoethyl succinate chloride or monoethyl succinate bromide, allowed to react, and monitored by TLC until the reaction is complete; to the resultant is added an acid or a base to control the pH value at about 7.0-8.5; the organic phase is precipitated and separated; to the organic phase is added water, cooled to −20° C.-10° C.; upon the solid is precipitated completely, the mixture is filtered, the resulting solid is recrystalized with water and one or more of a C1-C6 lower alcohol, a C2-C6 lower nitrile, a C2-C8 lower ether, a C3-C8 lower ketone or C1-C6 lower halogenated hydrocarbons as solvent once or more times, cooled to −20° C.-10° C., filtered, dried to obtain erythromycin ethylsuccinate crystalline hydrate;

후처리

  1. stirringstirred
  2. temperaturecooled to 20° C. or below
  3. customto react
  4. additionto the resultant is added an acid
  5. customthe organic phase is precipitated
  6. customseparated
  7. additionto the organic phase is added water
  8. temperaturecooled to −20° C.-10° C.
  9. customupon the solid is precipitated completely
  10. filtrationthe mixture is filtered
  11. customthe resulting solid is recrystalized with water and one or more of a C1-C6 lower alcohol
  12. temperaturea C2-C6 lower nitrile, a C2-C8 lower ether, a C3-C8 lower ketone or C1-C6 lower halogenated hydrocarbons as solvent once or more times, cooled to −20° C.-10° C.
  13. filtrationfiltered
  14. customdried

출처 및 근거

ORD 기록
ord-75738953660c40d2a5f43ae562378a52
출처 데이터셋
uspto-grants-2015_12
특허 번호
US09221862B2

연결된 노트

불러오는 중…